Home Biosimilar Antibodies Metabolism PCSK9 antibody Ralpancizumab (Anti-PCSK9) For research use only.
Not for use in humans.

Ralpancizumab (Anti-PCSK9)

Synonyms: PF-05335810

Ralpancizumab (Anti-PCSK9) is a monoclonal antibody targeting selective proprotein convertase subtilisin kexin 9 (PCSK9). It has the potential in hemorrhagic stroke, hypercholesterolemic, dyslipidemia treatment. MW 145.28 KD.

Ralpancizumab (Anti-PCSK9)

Purity & Quality Control

Choose Selective PCSK9 Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Ralpancizumab (Anti-PCSK9) is a monoclonal antibody targeting selective proprotein convertase subtilisin kexin 9 (PCSK9). It has the potential in hemorrhagic stroke, hypercholesterolemic, dyslipidemia treatment. MW 145.28 KD.

Product Details

CAS No. 1407495-04-8
Isotype Human IgG2SA
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Ralpancizumab (Anti-PCSK9) | Ralpancizumab (Anti-PCSK9) supplier | purchase Ralpancizumab (Anti-PCSK9) | Ralpancizumab (Anti-PCSK9) cost | Ralpancizumab (Anti-PCSK9) manufacturer | order Ralpancizumab (Anti-PCSK9) | Ralpancizumab (Anti-PCSK9) distributor